cicatrix crema
guna - centella asiatica, pinus sylvestris - crema - aqua, methylpolysiloxane, ceramide 3, ceramide 611, ceramide 1, phytosphingosine, cholesteroi, sodium lauroyl lactylate, xanthan gum, cetearyl alcohol, glycerin, ppg-11 stearyl ether, steareth-2, centella asiatica, stearic acid, pinus sylvestris - dermocosmetici - trattamento estetico di segni e cicatrici
symkevi
vertex pharmaceuticals (ireland) limited - tezacaftor, ivacaftor - fibrosi cistica - altri prodotti per il sistema respiratorio - symkevi is indicated in a combination regimen with ivacaftor tablets for the treatment of patients with cystic fibrosis (cf) aged 6 years and older who are homozygous for the f508del mutation or who are heterozygous for the f508del mutation and have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (cftr) gene: p67l, r117c, l206w, r352q, a455e, d579g, 711+3a→g, s945l, s977f, r1070w, d1152h, 2789+5g→a, 3272 26a→g, and 3849+10kbc→t.
deferasirox mylan
mylan pharmaceuticals limited - deferasirox - iron overload; beta-thalassemia - agenti chelanti del ferro - deferasirox mylan è indicato per il trattamento del sovraccarico cronico di ferro dovuto a frequenti trasfusioni di sangue (≥7 ml/kg/mese di globuli rossi concentrati) in pazienti con beta talassemia major di età 6 anni e olderthe trattamento del sovraccarico cronico di ferro dovuto a emotrasfusioni quando deferoxamina terapia è controindicata o inadeguata nei seguenti gruppi di pazienti:in pazienti pediatrici con beta talassemia major con sovraccarico di ferro dovuto a frequenti trasfusioni di sangue (≥7 ml/kg/mese di globuli rossi concentrati) di età compresa tra 2 a 5 anni,in pazienti adulti e pediatrici con beta talassemia major con sovraccarico di ferro dovuto a frequenti emotrasfusioni (.
orkambi
vertex pharmaceuticals (ireland) limited - lumacaftor, ivacaftor - fibrosi cistica - altri prodotti per il sistema respiratorio - orkambi compresse sono indicate per il trattamento della fibrosi cistica (cf) in pazienti di età compresa tra 6 anni e più che sono omozigoti per la mutazione f508del cftr gene. orkambi granules are indicated for the treatment of cystic fibrosis (cf) in children aged 1 year and older who are homozygous for the f508del mutation in the cftr gene.
zinforo
pfizer ireland pharmaceuticals - ceftaroline fosamil - community-acquired infections; skin diseases, infectious; pneumonia - antibatterici per uso sistemico, - zinforo is indicated for the treatment of the following infections in neonates, infants, children, adolescents and adults: , complicated skin and soft tissue infections (cssti), community-acquired pneumonia (cap) , consideration should be given to official guidance on the appropriate use of antibacterial agents.
qinlock
deciphera pharmaceuticals (netherlands) b.v. - ripretinib - tumori stromali gastrointestinali - agenti antineoplastici - qinlock is indicated for the treatment of adult patients with advanced gastrointestinal stromal tumour (gist) who have received prior treatment with three or more kinase inhibitors, including imatinib.
mycapssa
amryt pharmaceuticals dac - octreotide acetate - acromegalia - ormoni ipofisari e ipotalamici e analoghi - mycapssa is indicated for maintenance treatment in adult patients with acromegaly who have responded to and tolerated treatment with somatostatin analogues.
sunlenca
gilead sciences ireland unlimited company - lenacapavir sodium - infezioni da hiv - antivirali per uso sistemico - sunlenca injection, in combination with other antiretroviral(s), is indicated for the treatment of adults with multidrug resistant hiv 1 infection for whom it is otherwise not possible to construct a suppressive anti viral regimen (see sections 4. 2 e 5. sunlenca tablet, in combination with other antiretroviral(s), is indicated for the treatment of adults with multidrug resistant hiv 1 infection for whom it is otherwise not possible to construct a suppressive anti viral regimen, for oral loading prior to administration of long-acting lenacapavir injection (see sections 4. 2 e 5.
acido zoledronico seacross pharmaceuticals
seacross pharmaceuticals limited - acido zoledronico - acido zoledronico
enrylaze
jazz pharmaceuticals ireland limited - crisantaspase - linfoma di leucemia linfoblastica a cellule precursori - agenti antineoplastici - enrylaze is indicated as a component of a multi-agent chemotherapeutic regimen for the treatment of acute lymphoblastic leukaemia (all) and lymphoblastic lymphoma (lbl) in adult and paediatric patients (1 month and older) who developed hypersensitivity or silent inactivation to e. coli-derived asparaginase.